Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2024	Jul. 02, 2023	Jul. 03, 2022
Operating activities:
Net income (loss)	$ (6,105)	$ (44,702)	$ 29,610
Reconciliation of net income (loss) to net cash provided by operating activities net of acquisitions:
Goodwill and Intangible Asset Impairment	19,762	64,586	0
Depreciation and amortization	53,752	53,673	49,078
Amortization of deferred financing costs	724	1,834	1,269
Deferred income taxes	(11,732)	(4,608)	1,579
Bad debt expense (recoveries)	251	3,991	(411)
Stock-based compensation	10,688	8,334	7,947
Other non-cash items	310	95	3,194
Changes in operating items:
Trade receivables	2,143	(597)	(2,452)
Inventories	14,572	57,591	(85,047)
Prepaid and other	2,913	12,554	6,731
Accounts payable and accrued expenses	6,404	(38,623)	(6,595)
Other assets and other liabilities	1,317	1,223	286
Net cash provided by operating activities	94,999	115,351	5,189
Investing activities:
Acquisitions, net of cash acquired	(3,672)	(6,151)	(21,280)
Capital expenditures	(38,632)	(44,646)	(66,408)
Purchase of equity investments	0	(32)	(2,000)
Net cash used in investing activities	(42,304)	(50,829)	(89,688)
Financing activities:
Acquisition of treasury stock	(10,394)	(1,239)	(38,171)
Proceeds from exercise of employee stock options	329	0	846
Proceeds from bank borrowings	82,000	395,900	125,000
Repayment of bank borrowings	(92,000)	(360,900)	(145,000)
Debt issuance costs	0	(2,941)	(284)
Net cash (used in) provided by financing activities	(20,065)	30,820	(57,609)
Net change in cash and cash equivalents	32,630	95,342	(142,108)
Cash and cash equivalents:
Beginning of year	126,807	31,465	173,573
End of year	$ 159,437	$ 126,807	$ 31,465